BlackRock’s Intensity Therapeutics INTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,835
| Closed | -$43K | – | 5446 |
|
|
2025
Q1 | $43K | Sell |
21,835
-417
| -2% | -$821 | ﹤0.01% | 4900 |
|
|
2024
Q4 | $39.2K | Buy |
22,252
+139
| +0.6% | +$245 | ﹤0.01% | 4941 |
|
|
2024
Q3 | $84.5K | Buy |
22,113
+8,210
| +59% | +$31.4K | ﹤0.01% | 4655 |
|
|
2024
Q2 | $68.1K | Buy |
13,903
+3,179
| +30% | +$15.6K | ﹤0.01% | 4740 |
|
|
2024
Q1 | $55.8K | Sell |
10,724
-264
| -2% | -$1.37K | ﹤0.01% | 4786 |
|
|
2023
Q4 | $94.2K | Buy |
10,988
+749
| +7% | +$6.42K | ﹤0.01% | 4745 |
|
|
2023
Q3 | $40.6K | Buy |
+10,239
| New | +$40.6K | ﹤0.01% | 4969 |
|